Clinical Trial Update: Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating add-on ramelteon for sleep and circadian rhythm disruption in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Ramelteon (ramelteon)

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED